Synthesis and antinociceptive activity of chimonanthines and pyrrolidinoindoline-Type alkaloids
Abstract
Hodgkinsine, a trimeric pyrrolidinoindoline type alkaloid, present as a major constituent of
Psychotria spp. (Rubiaceae), has shown to produce dose-dependent, naloxone reversible, analgesic effect in thermal models of nociception and in the capsaicin-induced pain. SAR studies have been initiated by synthesizing the three diastereomeric dimers (chimonanthines) (
11–
13) which were evaluated in vitro and in vivo along with the synthetic intermediates. Strong binding affinities for μ opioid receptors were found for (−)- and (+)-chimonanthine monourethanes (
9 and
10), whereas (−)-, (+)- and (meso)-chimonanthine (
11–
13) and hodgkinsine displayed low affinity. In vivo data have shown that only (+)-chimonanthine (
12) and calycosidine resemble the analgesic profile found for hodgkinsine.
Graphical Abstract
(+)-, (−)-, (meso)-chimonanthine and the pyrrolidinoindoline-type intermediates from the synthetic pathway were tested in in vitro, in vivo models of analgesia, and compared to the active natural compound hodgkinsine, a trimeric pyrrolidinoindoline alkaloid isolated from
Psychotria colorata (Rubiaceae).